Oral Weekly Risperidone for Schizophrenia: Positive Phase 3 Study Data

New positive pivotal phase 3 study data released on oral weekly risperidone for schizophrenia.

Related Keywords

Richard Scranton ,Jessica Ballinger ,Roman Adobestock , ,Negative Syndrome Scale ,Schizophrenia ,Risperidone ,Schizoaffective Disorder ,